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It is a great pleasure for me as Chairman, Board of Directors of the Japan Diabetes Society to extend my warmest and most heartfelt congratulations to all those involved on this momentous and exciting occasion -- that is, the inaugural publication of the *Journal of Diabetes Investigation* (JDI). This journal is the official publication of the Asian Association for the Study of Diabetes (AASD), which was established in March 2009, and is fully supported in its endeavors by 17 national diabetes associations and societies throughout the region. With such a wide base of support covering both developing and developed Asian countries, the JDI is sure to become the core Asian medical publication in diabetes research.

The inaugural issue sets an extremely high standard and I know that this is a standard that the Editorial Board and publishers are wholeheartedly committed to maintaining. With diabetes becoming an increasing problem throughout Asia, it is extremely timely that there is a publication focusing on issues of particular relevance to populations throughout the region. Not only is it recognized that there are important differences between the features of diabetes in Asian and Western countries, both in terms of pathogenesis and treatment, but in addition there are very important differences throughout the Asian region relating to diabetes management that need a forum in which they can be addressed.

The commitment by the Editorial Board to providing a journal of international repute means that as well as reporting from an Asian perspective they will also publish the latest international research relating to diabetes care. In addition, the journal will look in great depth at issues that reflect specific Asian situations. Articles to be published will relate to both basic research, including molecular aspects and pathophysiology, as well as clinical and public health issues. This will therefore include the topics of prevention, treatment, education and nutrition, as well as economic and psychological aspects. Original research, country reports, reviews, case reports as well as letters, editorials and the latest news will be covered. The JDI will provide a much needed and valuable forum in which Asian researchers, as well as researchers from other parts of the world, will be able to report diabetes research and treatment throughout their diverse region.

I would like to specifically extend my admiration and congratulations to Dr Nigishi Hotta, Editor‐in‐Chief and Dr Yutaka Seino, President of AASD, for all their efforts in bringing the publication of this new journal to fruition. As can be imagined, an enterprise of this scale involves a huge commitment and effort, both of which have been supplied in abundance by these two extremely well respected specialists. I wish them well in their enterprise, which I am sure will not only become the pre‐eminent diabetes journal in Asia, but also one of great international renown.
